D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Comcast
CMCSA
|
+$346M |
| 2 |
Wells Fargo
WFC
|
+$285M |
| 3 |
IBM
IBM
|
+$264M |
| 4 |
Qualcomm
QCOM
|
+$252M |
| 5 |
Mondelez International
MDLZ
|
+$214M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
+$377M |
| 2 |
PayPal
PYPL
|
+$310M |
| 3 |
NVIDIA
NVDA
|
+$267M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$266M |
| 5 |
AABA
Altaba Inc. Common Stock
AABA
|
+$264M |
Sector Composition
| 1 | Technology | 17.21% |
| 2 | Healthcare | 12.97% |
| 3 | Consumer Discretionary | 12.74% |
| 4 | Financials | 10.33% |
| 5 | Communication Services | 10.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Pacira BioSciences
PCRX
$1.2B
| $370K | ﹤0.01% |
+9,851
| New | +$370K |
|
2127
NCS Multistage Holdings
NCSM
$131M
| $369K | ﹤0.01% |
+767
| New | +$369K |
|
2128
Lennox International
LII
$19.6B
| $367K | ﹤0.01% |
+2,048
| New | +$367K |
|
2129
AngloGold Ashanti
AU
$32.6B
| $365K | ﹤0.01% |
39,331
-18,264
| -32% | -$169K |
|
2130
KeyCorp
KEY
$21.1B
| $365K | ﹤0.01% |
19,420
-743,046
| -97% | -$14M |
|
|
SPN
2131
DELISTED
Superior Energy Services, Inc.
SPN
| $365K | ﹤0.01% |
+34,179
| New | +$365K |
|
2132
Invesco Mortgage Capital
IVR
$515M
| $364K | ﹤0.01% |
2,127
+664
| +45% | +$114K |
|
2133
Alamo Group
ALG
$2.5B
| $363K | ﹤0.01% |
3,381
-100
| -3% | -$10.7K |
|
|
MITT
2134
AG Mortgage Investment Trust
MITT
$245M
| $363K | ﹤0.01% |
+6,293
| New | +$363K |
|
|
VWTR
2135
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $363K | ﹤0.01% |
+21,747
| New | +$363K |
|
2136
United Natural Foods
UNFI
$1.72B
| $362K | ﹤0.01% |
8,701
-19,034
| -69% | -$792K |
|
2137
Sierra Bancorp
BSRR
$408M
| $361K | ﹤0.01% |
+13,301
| New | +$361K |
|
2138
COPT Defense Properties
CDP
$3.45B
| $361K | ﹤0.01% |
+11,001
| New | +$361K |
|
|
STBZ
2139
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
| $360K | ﹤0.01% |
12,549
+480
| +4% | +$13.8K |
|
2140
Assembly Biosciences
ASMB
$171M
| $359K | ﹤0.01% |
+856
| New | +$359K |
|
|
OLP
2141
One Liberty Properties
OLP
$492M
| $359K | ﹤0.01% |
14,739
-2,619
| -15% | -$63.8K |
|
2142
Gannett
GCI
$601M
| $358K | ﹤0.01% |
24,192
-11,866
| -33% | -$176K |
|
|
DEA
2143
Easterly Government Properties
DEA
$1.06B
| $354K | ﹤0.01% |
+6,855
| New | +$354K |
|
2144
LG Display
LPL
$4.33B
| $354K | ﹤0.01% |
+26,351
| New | +$354K |
|
2145
Phibro Animal Health
PAHC
$1.67B
| $354K | ﹤0.01% |
9,547
-916
| -9% | -$34K |
|
2146
Ocular Therapeutix
OCUL
$2.27B
| $353K | ﹤0.01% |
57,146
+14,768
| +35% | +$91.2K |
|
2147
Roper Technologies
ROP
$55.2B
| $353K | ﹤0.01% |
1,449
-293
| -17% | -$71.4K |
|
2148
Ameresco
AMRC
$1.48B
| $350K | ﹤0.01% |
44,817
+15,078
| +51% | +$118K |
|
|
AAC
2149
DELISTED
AAC Holdings, Inc.
AAC
| $349K | ﹤0.01% |
35,123
-7,304
| -17% | -$72.6K |
|
2150
Select Medical
SEM
$1.54B
| $347K | ﹤0.01% |
33,571
+5,566
| +20% | +$57.5K |
|